Expression of NADPH oxidase in human pancreatic islets

Life Sci. 2012 Sep 17;91(7-8):244-9. doi: 10.1016/j.lfs.2012.07.004. Epub 2012 Jul 17.

Abstract

Aims: NADPH oxidase (NOX) is a known source of superoxide anions in phagocytic and non-phagocytic cells. In this study, the presence of this enzyme in human pancreatic islets and the importance of NADPH oxidase in human β-cell function were investigated.

Main methods and key findings: In isolated human pancreatic islets, the expression of NADPH oxidase components was evidenced by real-time PCR (p22(PHOX), p47(PHOX) and p67(PHOX)), Western blotting (p47(PHOX) and p67(PHOX)) and immunohistochemistry (p47(PHOX), p67(PHOX) and gp91(PHOX)). Immunohistochemistry experiments showed co-localization of p47(PHOX), p67(PHOX) and gp91(PHOX) (isoform 2 of NADPH oxidase-NOX2) with insulin secreting cells. Inhibition of NADPH oxidase activity impaired glucose metabolism and glucose-stimulated insulin secretion.

Significance: These findings demonstrate the presence of the main intrinsic components of NADPH oxidase comprising the NOX2 isoform in human pancreatic islets, whose activity also contributes to human β-cell function.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Base Sequence
  • Blotting, Western
  • DNA Primers
  • Enzyme Inhibitors / pharmacology
  • Glucose / metabolism
  • Humans
  • Immunohistochemistry
  • In Vitro Techniques
  • Insulin / metabolism
  • Insulin Secretion
  • Islets of Langerhans / enzymology*
  • Islets of Langerhans / metabolism
  • Middle Aged
  • NADPH Oxidases / antagonists & inhibitors
  • NADPH Oxidases / metabolism*
  • Real-Time Polymerase Chain Reaction

Substances

  • DNA Primers
  • Enzyme Inhibitors
  • Insulin
  • NADPH Oxidases
  • Glucose